adcirca
Generic: tadalafil
Labeler: united therapeutics corporationDrug Facts
Product Profile
Brand Name
adcirca
Generic Name
tadalafil
Labeler
united therapeutics corporation
Dosage Form
TABLET
Routes
Active Ingredients
tadalafil 20 mg/1
Manufacturer
Identifiers & Regulatory
Product NDC
66302-467
Product ID
66302-467_76c30323-0981-499c-b552-1a43f01c89c8
Product Type
HUMAN PRESCRIPTION DRUG
Marketing Category
NDA
Application Number
NDA022332
Listing Expiration
2026-12-31
Marketing Start
2009-05-22
Pharmacologic Class
Established (EPC)
Mechanism of Action
Normalized Code Variants
Searchable formats for this product NDC code
Digits Only
66302467
Hyphenated Format
66302-467
Supplemental Identifiers
RxCUI
UPC
UNII
NUI
Packaging Origin
Original Packager
Resolved Product View
Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.
Resolved Identity
Brand Name
adcirca (source: ndc)
Generic Name
tadalafil (source: ndc)
Application Number
NDA022332 (source: ndc)
Routes
source: ndc
Resolved Composition
Strengths
- 20 mg/1
Packaging
- 60 TABLET in 1 BOTTLE (66302-467-60)
Packages (1)
Ingredients (1)
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "76c30323-0981-499c-b552-1a43f01c89c8", "openfda": {"nui": ["N0000175599", "N0000020026"], "upc": ["0366302467607"], "unii": ["742SXX0ICT"], "rxcui": ["849866", "2123194"], "spl_set_id": ["ff61b237-be8e-461b-8114-78c52a8ad0ae"], "pharm_class_epc": ["Phosphodiesterase 5 Inhibitor [EPC]"], "pharm_class_moa": ["Phosphodiesterase 5 Inhibitors [MoA]"], "manufacturer_name": ["United Therapeutics Corporation"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "60 TABLET in 1 BOTTLE (66302-467-60)", "package_ndc": "66302-467-60", "marketing_start_date": "20090803"}], "brand_name": "ADCIRCA", "product_id": "66302-467_76c30323-0981-499c-b552-1a43f01c89c8", "dosage_form": "TABLET", "pharm_class": ["Phosphodiesterase 5 Inhibitor [EPC]", "Phosphodiesterase 5 Inhibitors [MoA]"], "product_ndc": "66302-467", "generic_name": "Tadalafil", "labeler_name": "United Therapeutics Corporation", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "ADCIRCA", "active_ingredients": [{"name": "TADALAFIL", "strength": "20 mg/1"}], "application_number": "NDA022332", "marketing_category": "NDA", "marketing_start_date": "20090522", "listing_expiration_date": "20261231"}